Hodgkin Lymphoma News and Research

RSS
Doctors urging conference boycotts over abortion bans face uphill battle

Doctors urging conference boycotts over abortion bans face uphill battle

'Treating Naturally Occurring Disease’, explained by Founder, Professor Noel Fitzpatrick

'Treating Naturally Occurring Disease’, explained by Founder, Professor Noel Fitzpatrick

Cancer patients face increased risk of long-term mental health problems

Cancer patients face increased risk of long-term mental health problems

Do organic foods really offer better health benefits?

Do organic foods really offer better health benefits?

Cancer cases in the US continued to be underdiagnosed during the second year of the COVID-19 pandemic

Cancer cases in the US continued to be underdiagnosed during the second year of the COVID-19 pandemic

Breast cancer rises among Asian American and Pacific Islander women

Breast cancer rises among Asian American and Pacific Islander women

Exploring the distinct characteristics of Nodular Lymphocyte Predominant Hodgkin Lymphoma

Exploring the distinct characteristics of Nodular Lymphocyte Predominant Hodgkin Lymphoma

Small-town patients face big hurdles as rural hospitals cut cancer care

Small-town patients face big hurdles as rural hospitals cut cancer care

Quality-of-life measurements are essential in cancer care, study says

Quality-of-life measurements are essential in cancer care, study says

Researchers find the effect of pesticides on increased cancer risk is comparable to smoking for some cancers

Researchers find the effect of pesticides on increased cancer risk is comparable to smoking for some cancers

Study highlights infection as major post-CAR-T therapy challenge

Study highlights infection as major post-CAR-T therapy challenge

Research shows the ability of proteins to predict onset of many diverse diseases

Research shows the ability of proteins to predict onset of many diverse diseases

40% of US cancer cases linked to lifestyle choices

40% of US cancer cases linked to lifestyle choices

Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy response

Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy response

JAK inhibitor ruxolitinib enhances immunotherapy in Hodgkin lymphoma patients

JAK inhibitor ruxolitinib enhances immunotherapy in Hodgkin lymphoma patients

New armored CAR T cell therapy boosts response in Relapsed non-Hodgkin lymphoma patients

New armored CAR T cell therapy boosts response in Relapsed non-Hodgkin lymphoma patients

Proteins in the blood could warn people of cancer more than seven years before it is diagnosed

Proteins in the blood could warn people of cancer more than seven years before it is diagnosed

Study reveals latest cancer trends in Canada

Study reveals latest cancer trends in Canada

Toxic gas adds to a long history of pollution in Southwest Memphis

Toxic gas adds to a long history of pollution in Southwest Memphis

Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.